S

SMAIO SA
PAR:ALSMA

Watchlist Manager
SMAIO SA
PAR:ALSMA
Watchlist
Price: 6.7 EUR Market Closed
Market Cap: 37.9m EUR
Section:
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+10%
Revenue
Forecast
+53%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

ALSMA Price Targets Summary
SMAIO SA

Wall Street analysts forecast ALSMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALSMA is 7.4 EUR with a low forecast of 7.07 EUR and a high forecast of 7.88 EUR.

ALSMA Lowest Forecast
Wall Street Target
7.07 EUR
6% Upside
ALSMA Average Forecast
Wall Street Target
7.4 EUR
10% Upside
ALSMA Highest Forecast
Wall Street Target
7.88 EUR
18% Upside
Lowest
Price Target
7.07 EUR
6% Upside
Average
Price Target
7.4 EUR
10% Upside
Highest
Price Target
7.88 EUR
18% Upside
SMAIO SA Competitors:
Price Targets
LMAT
LeMaitre Vascular Inc
20% Upside
KRMD
Repro Med Systems Inc
35% Upside
ZBH
Zimmer Biomet Holdings Inc
12% Upside
SHL
Siemens Healthineers AG
25% Upside
LMAT
LeMaitre Vascular Inc
20% Upside
KRMD
Repro Med Systems Inc
35% Upside
ZBH
Zimmer Biomet Holdings Inc
12% Upside
SHL
Siemens Healthineers AG
25% Upside
O
OPTOMED
Optomed Oyj
17% Upside
BSX
Boston Scientific Corp
25% Upside

Revenue
Forecast

Revenue Estimate
SMAIO SA

For the last 5 years the compound annual growth rate for SMAIO SA's revenue is 70%. The projected CAGR for the next 3 years is 53%.

70%
Past Growth
53%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
SMAIO SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
SMAIO SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
What are analyst estimates?

See Also

Summary
ALSMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALSMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALSMA stock valuation using valuation multiples.
Wall Street Estimates
ALSMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALSMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALSMA's stock price target?
Price Target
7.4 EUR

According to Wall Street analysts, the average 1-year price target for ALSMA is 7.4 EUR with a low forecast of 7.07 EUR and a high forecast of 7.88 EUR.

What is SMAIO SA's Revenue forecast?
Projected CAGR
53%

For the last 5 years the compound annual growth rate for SMAIO SA's revenue is 70%. The projected CAGR for the next 3 years is 53%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 292,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.